GW & Wade’s Eaton Vance Senior Floating-Rate Fund EFR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$163K Buy
12,869
+299
+2% +$3.65K 0.01% 397
2023
Q3
$152K Hold
12,570
0.01% 389
2023
Q2
$148K Hold
12,570
0.01% 375
2023
Q1
$142K Hold
12,570
0.01% 364
2022
Q4
$138K Hold
12,570
0.01% 373
2022
Q3
$140K Buy
+12,570
New +$152K 0.01% 367
2017
Q4
Sell
-12,530
Closed -$187K 224
2017
Q3
$187K Hold
12,530
0.02% 231
2017
Q2
$187K Hold
12,530
0.02% 224
2017
Q1
$190K Hold
12,530
0.02% 230
2016
Q4
$185K Hold
12,530
0.03% 214
2016
Q3
$177K Hold
12,530
0.03% 219
2016
Q2
$164K Hold
12,530
0.03% 224
2016
Q1
$161K Hold
12,530
0.03% 203
2015
Q4
$155K Hold
12,530
0.03% 204
2015
Q3
$165K Hold
12,530
0.04% 210
2015
Q2
$172K Sell
12,530
-3,575
-22% -$51.6K 0.03% 220
2015
Q1
$233K Buy
+16,105
New +$225K 0.04% 213

Other funds holding EFR

GW & Wade's EFR Position: Q4 2023 in Review

GW & Wade increased its Eaton Vance Senior Floating-Rate Fund (EFR) stake by 2.4% in Q4 2023, buying an estimated $3.65K and bringing the position to 12,869 shares worth $163K. The position accounts for 0.01% of the portfolio, ranked #397.

GW & Wade first reported a position in EFR in Q1 2015 and has held it in 17 quarters since. The position peaked at $233K in Q1 2015. 86 funds tracked by Wall St. Rank hold EFR as of Q4 2023.

  • GW & Wade held 12,869 shares of Eaton Vance Senior Floating-Rate Fund worth $163K as of Q4 2023.
  • GW & Wade bought 299 Eaton Vance Senior Floating-Rate Fund shares in Q4 2023, an estimated $3.65K.
  • Eaton Vance Senior Floating-Rate Fund made up 0.01% of GW & Wade's portfolio in Q4 2023, its #397 holding.
  • GW & Wade first reported a position in Eaton Vance Senior Floating-Rate Fund in Q1 2015 and has held it in 17 quarters since.
  • GW & Wade's Eaton Vance Senior Floating-Rate Fund position peaked at $233K in Q1 2015.
  • 86 funds tracked by Wall St. Rank held Eaton Vance Senior Floating-Rate Fund as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.